Navigation Links
Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment
Date:5/17/2013

FARMINGTON, Conn., May 17, 2013 /PRNewswire-iReach/ -- The escalation of new biological drugs, including antibodies and recombinant proteins, is placing renewed emphasis on alternate delivery technologies. Alternate delivery technologies are on the rise as a number of factors are converging to create both risk and opportunity for pharmaceutical makers and their delivery device partners. These include new classes of drugs for previously refractory conditions, the growing trend toward self-administration for chronic diseases, shifting patient demographics in industrial countries, caregiver safety legislation, and continued pressure to control healthcare costs.

(Photo: http://photos.prnewswire.com/prnh/20130517/CG15876)

These factors are giving rise to a new generation of sophisticated, application-specific injection, inhalation and transdermal drug products designed to satisfy caregiver and patient preferences while addressing managed care initiatives and the formulation limitations of new classes of therapeutic drugs. Because of their ability to safely and reliably satisfy treatment protocols and compliance goals, non-oral drug delivery products will have a significant impact on the future of drug self-administration.

The new Drug Self-Administration to 2018: Drug Products, Indications, Markets and Forecasts report is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the drug delivery sector.

Request a free sample from Global Information's market research portal to learn more or easily order your copy online here.

For more recently released reports from Greystone Research Associates please visit the following links:

Transdermal Drug Patches to 2018: Products, Indications, Markets and Forecasts

Published March, 2013

Injectable Drug Delivery to 2018: Drugs, Devices, Targets, Therapeutics and Forecasts

Published March, 2013

Autoinjectors to 2018: Devices, Therapeutics, Market, Strategies and Prospects

Published March, 2013

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 400 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 30 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

About Greystone Research Associates As life science consultants, Greystone Research Associates focuses on one industry and one objective - providing management guidance in an increasingly dynamic medical technology marketplace. The value Greystone Research Associates provides to their clients and subscribers is best illustrated by their ability to consistently provide strategic direction and market knowledge that contributes to their tactical and strategic decision process. Greystone Research Associates delivers their knowledge franchise through concise market appraisals, company analysis, and technology reports. Their publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge necessary to refine and execute their marketing plans and achieve their financial targets.

Media Contact:  Joe Malley Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
2. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
3. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
4. Access Pharmaceuticals Reports First Quarter Results
5. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
6. Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors
7. Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year
8. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
9. Auxilium Pharmaceuticals, Inc. To Present At The UBS Global Health Care Conference
10. Savient Pharmaceuticals Reports First Quarter 2013 Financial Results
11. The Law Offices of Marc S. Henzel Announces Class Action Lawsuit Against Aveo Pharmaceuticals, Inc. and Certain Officers -- (Nasdaq: AVEO) was filed on behalf of stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... 21, 2017 Medical Oxygen Concentrators Market: ... http://www.reportlinker.com/p04711311-summary/view-report.html Medical oxygen concentrators are used ... diseases. Patients having low level of oxygen in ... Oxygen concentrators are to be used only with ... Medical oxygen concentrators work either on rechargeable lithium ...
(Date:2/21/2017)... YORK , Feb. 21, 2017   ... focused on the development of innovative immuno-oncology cancer ... statistically significant data from its Phase 2 trial ... for the treatment of non-small cell lung cancer ... presentation at this year,s ASCO-SITC Clinical Immuno-Oncology Symposium ...
(Date:2/21/2017)... 21, 2017 Centurion Medical Products, a ... care, is making a major stride in emergency ... its IRIG-8™Wound Irrigation System . ... deliver copious volumes of irrigation solution to acute ... a significant improvement to the traditional syringe with ...
Breaking Medicine Technology:
(Date:2/21/2017)... , ... February 21, 2017 , ... Doctors on Liens ... directed by Dr. Kendell Mendonca , to its growing network of doctors in ... including injuries stemming from car accidents such as whiplash, back pain, neck pain, hip ...
(Date:2/21/2017)... ... 2017 , ... American Veterinarian™, the premier multimedia provider of ... first bi-monthly issue of 2017 in February. The inaugural issue will offer expert ... , In making the announcement, American Veterinarian™ Publisher Chris Hennessy said, “We ...
(Date:2/21/2017)... ... February 21, 2017 , ... One ... untreated despite the medical, mental health, and financial consequences of inaction. On March ... take action if they have concerns about their hearing. , Effective treatment in ...
(Date:2/20/2017)... ... February 20, 2017 , ... MRI screening improves early diagnosis of ... from Germany published online in the journal Radiology . , MRI has ... than mammography and ultrasound. Currently, guidelines reserve breast MRI screening for women who have ...
(Date:2/20/2017)... FL (PRWEB) , ... February 20, 2017 , ... ... beth[at]orbitahealth[dot]com, +1 (414) 213-8818 , Orbita, Inc., a leading provider of innovative software ... solution for increasing patient engagement and optimizing care journey management for home healthcare. ...
Breaking Medicine News(10 mins):